AI ASSISTANT
Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
salsalate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| analgesic anti-inflammatory | 2420 | 552-94-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 3 | g | O |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BA (Bioavailability) | 100 % |
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2A,ACVR2B,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GRK3,GSK3B,ITK,JAK1,JAK2,KIT,MAP2K6,MAP3K14,MAP3K21,MAP3K7,MAPK1,MAPK12,MAPK7,MAPK8,MAPK9,MAPKAPK2,MARK4,MTOR,NTRK2,PDK1,PDK2,PDPK1,PIK3CB,PIK3CD,PIM2,PLK1,PRKCD,PRKDC,SGK1,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ZAP70 | 57 | |||
| kinase-selectivity-class | ACVR2A,ACVR2B,AURKB,AURKC,AXL,BRAF,CDK4,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,GRK2,GSK3B,JAK2,MAP2K3,MAP2K6,MAP3K14,MAPK1,MAPK12,MAPK7,MAPK8,MARK4,MTOR,PDK4,PIK3CD,PRKDC,SIK2,STK10,STK33,SYK,TEK,TGFBR1,TTK,ULK1 | 36 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| International normalised ratio increased | 36.91 | 29.16 | 15 | 423 | 48153 | 42572744 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| International normalised ratio increased | 28.35 | 27.51 | 13 | 712 | 86759 | 110501815 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | N02BA06 | NERVOUS SYSTEM ANALGESICS OTHER ANALGESICS AND ANTIPYRETICS Salicylic acid and derivatives |
| MeSH PA | D000700 | Analgesics |
| MeSH PA | D000893 | Anti-Inflammatory Agents |
| MeSH PA | D000894 | Anti-Inflammatory Agents, Non-Steroidal |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D018501 | Antirheumatic Agents |
| MeSH PA | D018689 | Sensory System Agents |
| MeSH PA | D018712 | Analgesics, Non-Narcotic |
| CHEBI has role | CHEBI:35475 | non-steroidal anti-inflammatory drug |
| CHEBI has role | CHEBI:35480 | analgesic |
| CHEBI has role | CHEBI:35481 | non-narcotic analgesic |
| CHEBI has role | CHEBI:35526 | hypoglycemic agent |
| CHEBI has role | CHEBI:35610 | antineoplastic agent |
| CHEBI has role | CHEBI:35625 | EC 3.5.2.6 (β-lactamase) inhibitor |
| CHEBI has role | CHEBI:35842 | antirheumatic drug |
| CHEBI has role | CHEBI:50266 | prodrug |
| CHEBI has role | CHEBI:50864 | insulin-sensitizing drug |
| CHEBI has role | CHEBI:74518 | anti-obesity agent |
| CHEBI has role | CHEBI:75835 | anti-anaemic agent |
| CHEBI has role | CHEBI:145947 | antiatherosclerotic agent |
| CHEBI has role | CHEBI:35441 | antiinfective agent |
| CHEBI has role | CHEBI:35554 | cardiovascular drug |
| CHEBI has role | CHEBI:35718 | antifungal agent |
| CHEBI has role | CHEBI:37848 | plant hormone |
| CHEBI has role | CHEBI:50176 | keratolytic drug |
| CHEBI has role | CHEBI:50177 | dermatologic drug |
| CHEBI has role | CHEBI:50247 | antidote |
| CHEBI has role | CHEBI:50249 | anticoagulant |
| CHEBI has role | CHEBI:50748 | antipsoriatic |
| CHEBI has role | CHEBI:66981 | ophthalmology drug |
| CHEBI has role | CHEBI:67079 | anti-inflammatory agent |
| CHEBI has role | CHEBI:73181 | EC 1.11.1.11 (<small>L</small>-ascorbate peroxidase) inhibitor |
| CHEBI has role | CHEBI:76924 | plant metabolite |
| CHEBI has role | CHEBI:84735 | algal metabolite |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000935 | Antifungal Agents |
| MeSH PA | D003879 | Dermatologic Agents |
| MeSH PA | D007641 | Keratolytic Agents |
Related Drugs by ATC class:
N02BA Salicylic acid and derivatives 11 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Rheumatoid arthritis | indication | 69896004 | DOID:7148 |
| Osteoarthritis | indication | 396275006 | |
| Gastritis | contraindication | 4556007 | DOID:4029 |
| Gastrointestinal ulcer | contraindication | 40845000 | |
| Body fluid retention | contraindication | 43498006 | |
| Disorder of cardiovascular system | contraindication | 49601007 | DOID:1287 |
| Vitamin K deficiency | contraindication | 52675005 | DOID:11249 |
| Nasal polyp | contraindication | 52756005 | |
| Hepatic failure | contraindication | 59927004 | |
| Blood coagulation disorder | contraindication | 64779008 | DOID:1247 |
| Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
| Factor II deficiency | contraindication | 73975000 | |
| Gastrointestinal hemorrhage | contraindication | 74474003 | |
| Thrombotic thrombocytopenic purpura | contraindication | 78129009 | DOID:10772 |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Thyrotoxicosis | contraindication | 90739004 | DOID:7997 |
| Hemophilia | contraindication | 90935002 | |
| Anemia due to enzyme deficiency | contraindication | 111577008 | |
| Gastroesophageal reflux disease | contraindication | 235595009 | DOID:8534 |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Anemia | contraindication | 271737000 | DOID:2355 |
| Pregnancy, function | contraindication | 289908002 | |
| Cardiovascular event risk | contraindication | 395112001 | |
| Breastfeeding (mother) | contraindication | 413712001 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 3.37 | acidic |
| pKa2 | 9.43 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| 4018818 | VUID |
| N0000179234 | NUI |
| D00428 | KEGG_DRUG |
| 4018663 | VANDF |
| 4018818 | VANDF |
| C0073983 | UMLSCUI |
| CHEBI:9014 | CHEBI |
| SAL | PDB_CHEM_ID |
| CHEMBL154111 | ChEMBL_ID |
| DB01399 | DRUGBANK_ID |
| 5161 | PUBCHEM_CID |
| C014182 | MESH_SUPPLEMENTAL_RECORD_UI |
| 3267 | INN_ID |
| V9MO595C9I | UNII |
| 36108 | RXNORM |
| 1419 | MMSL |
| 5439 | MMSL |
| 5441 | MMSL |
| 9170 | MMSL |
| d00842 | MMSL |
| 001596 | NDDF |
| 001951 | NDDF |
| 13252002 | SNOMEDCT_US |
| 387072007 | SNOMEDCT_US |
| 387253001 | SNOMEDCT_US |
| 46741005 | SNOMEDCT_US |
| C0036079 | UMLSCUI |
| DB00936 | DRUGBANK_ID |
| 338 | PUBCHEM_CID |
| D020156 | MESH_DESCRIPTOR_UI |
| CHEBI:16914 | CHEBI |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10135-492 | TABLET, FILM COATED | 500 mg | ORAL | UNAPPROVED DRUG OTHER | 27 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10135-493 | TABLET, FILM COATED | 750 mg | ORAL | UNAPPROVED DRUG OTHER | 27 sections |
| Salsalate Rx | HUMAN PRESCRIPTION DRUG LABEL | 1 | 13273-209 | TABLET, FILM COATED | 500 mg | ORAL | UNAPPROVED DRUG OTHER | 28 sections |
| Salsalate Rx | HUMAN PRESCRIPTION DRUG LABEL | 1 | 13273-210 | TABLET, FILM COATED | 750 mg | ORAL | UNAPPROVED DRUG OTHER | 28 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21695-392 | TABLET | 750 mg | ORAL | Unapproved drug other | 28 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50682-507 | TABLET, FILM COATED | 500 mg | ORAL | Unapproved drug other | 25 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50682-508 | TABLET, FILM COATED | 750 mg | ORAL | Unapproved drug other | 25 sections |
| Salsalate | Human Prescription Drug Label | 1 | 57664-103 | TABLET | 500 mg | ORAL | Unapproved drug other | 28 sections |
| Salsalate | Human Prescription Drug Label | 1 | 57664-105 | TABLET | 750 mg | ORAL | Unapproved drug other | 28 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65162-512 | TABLET | 500 mg | ORAL | unapproved drug other | 16 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65162-513 | TABLET | 750 mg | ORAL | unapproved drug other | 16 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 68151-1923 | TABLET | 500 mg | ORAL | Unapproved drug other | 14 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 68151-1924 | TABLET | 750 mg | ORAL | Unapproved drug other | 14 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69367-615 | TABLET | 500 mg | ORAL | UNAPPROVED DRUG OTHER | 22 sections |
| Salsalate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69367-616 | TABLET | 750 mg | ORAL | UNAPPROVED DRUG OTHER | 22 sections |